Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Apollo Group, Inc (APOL - Analyst Report) reported adjusted earnings (excluding special items) of $1.22 per share in the first quarter of fiscal 2013, surpassing the Zacks Consensus Estimate of 90 cents by 36%. However, lower revenues resulted in a 3.2% downslide from the prior-year earnings of $1.26 per share.
Apollo Group reported net revenue of $1.1 billion in the first quarter of fiscal 2013, down 8.3% from the prior-year quarter due to 14.3% decline in degreed enrollment in University of Phoenix. Revenue, however, beat the Zacks Consensus Estimate of $1.03 billion by 6.8%.
We believe that Apollo beat the top and bottom line estimates on the back of better-than-expected enrollment results achieved by the University of Phoenix during the quarter. The decline in enrollment was narrower than the company guidance. However, revenue per students grew 3% year over year, driven by improved pricing and favorable students mix.
Enrollment Details
University of Phoenix – This segment offers bachelor’s, master’s and doctoral programs in 40 states in the U.S., the District of Columbia and Puerto Rico. It also offers online programs to students across the globe.
The University of Phoenix reported a decline of 14.3% in degreed enrollment to 319,700 students in the first quarter of fiscal 2013. New enrollment (or new degreed enrollment) at University of Phoenix declined 15.1% from the prior-year quarter to 54,100. The company results were better than the company’s expectation of 17% year over year decline.
Compared to the prior year quarter results, the company’s Associates Degree revenue in the first quarter of 2013 was $251.9 million, down 19.7%; Bachelor’s Degree revenue was $560.8 million, down 5.4%, Master’s Degree revenue declined 11% to $158.9 million and Doctoral Degree revenue was $20.7 million, down 12.7%.
Apollo Group has been witnessing persistent decline in enrollment due to the weak macroeconomic environment and subsequent decline in demand for courses (due to the hesitancy over taking a loan) in the U.S.
Other Details
The company incurred adjusted operating expenses of $817 million in the quarter, down 8.0% from the prior-year quarter, driven by decline in expenses. Instructional and student advisory cost decreased to $432.2 million during the quarter, down 4.7% year over year, driven by cost control initiatives taken by the company.
The company is taking several initiatives to drive growth in the upcoming quarters. The company intends to differentiate University of Phoenix as well as to diversify Apollo Group, in order to raise the quality of education offered to students and student outcome. Apollo’s other initiatives include investments in adaptive learning, curriculum development, new learning systems and student service platforms; and initiatives to connect education to careers. Also, the company is coordinating with 2,000 other corporate companies to educate their workforce.
Trimmed Outlook
At the first quarter conference call, the company issued the net revenue guidance range of $3.65 to $3.75 billion, narrower than prior expectations of $3.65 to $3.80 billion for fiscal 2013. The company continues to expect new degreed enrollment growth to become positive some time in fiscal 2013. Adjusted operating income is expected to be in the range of $500.0 to $550.0 million compared with the prior guidance of $525 to $575 million in fiscal 2013.
Revenue per student is expected to range from negative 1% to 2% for the remainder of fiscal 2013. Total marketing cost is expected to increase 15% during the second quarter 2013, driven by increased advertising expenditure.
A peer of DeVry, Inc. (DV - Analyst Report), Apollo carries a Zacks Rank #3 (Hold) for the near term. Currently, we have a Neutral recommendation on the company over the long term.
Overall, we like Apollo Group’s dominant market position as well as its efforts to address its challenges and improve business over the long term. Though encouraged by these initiatives, we still prefer to stay on the sidelines due to the trimmed guidance, choppy enrollment trend and possibility of regulatory changes.
Get the full Analyst Report on APOL - FREE
Get the full Analyst Report on DV - FREE